Isa Iber VD
Phase 1b/2: Isatuximab, Iberdomide, Bortezomib, Dexamethasone in Transplant Ineligible/Deferred Newly Diagnosed Myeloma
Near Add Your Location
Sorting 2 by
Dana-Farber Cancer Institute
Boston, MA
- Not yet accepting
Beth Israel Deaconess Medical Center
Boston, MA
- Not yet accepting
Showing 1-2 of 2
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.